Intestinal absorption, distribution and excretion of an orally administered polymeric antioxidant in rats and mice. 1978

T M Parkinson, and T Honohan, and F E Enderlin, and S C Halladay, and R L Hale, and de Keczer, and P L Dubin, and B A Ryerson, and A R Read

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005260 Female Females
D005503 Food Additives Substances used in the processing or storage of foods or animal feed including ANTIOXIDANTS; FOOD PRESERVATIVES; FOOD COLORING AGENTS; FLAVORING AGENTS; ANTI-INFECTIVE AGENTS; EXCIPIENTS and other similarly used substances. Many of the same substances are used as PHARMACEUTIC AIDS. Additive, Food,Additives, Food,Food Additive
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

T M Parkinson, and T Honohan, and F E Enderlin, and S C Halladay, and R L Hale, and de Keczer, and P L Dubin, and B A Ryerson, and A R Read
March 1982, Lipids,
T M Parkinson, and T Honohan, and F E Enderlin, and S C Halladay, and R L Hale, and de Keczer, and P L Dubin, and B A Ryerson, and A R Read
May 1990, Toxicology and applied pharmacology,
T M Parkinson, and T Honohan, and F E Enderlin, and S C Halladay, and R L Hale, and de Keczer, and P L Dubin, and B A Ryerson, and A R Read
June 1991, Toxicology and applied pharmacology,
T M Parkinson, and T Honohan, and F E Enderlin, and S C Halladay, and R L Hale, and de Keczer, and P L Dubin, and B A Ryerson, and A R Read
December 1977, Hiroshima journal of medical sciences,
T M Parkinson, and T Honohan, and F E Enderlin, and S C Halladay, and R L Hale, and de Keczer, and P L Dubin, and B A Ryerson, and A R Read
January 1975, Materia medica Polona. Polish journal of medicine and pharmacy,
T M Parkinson, and T Honohan, and F E Enderlin, and S C Halladay, and R L Hale, and de Keczer, and P L Dubin, and B A Ryerson, and A R Read
January 1985, Arzneimittel-Forschung,
T M Parkinson, and T Honohan, and F E Enderlin, and S C Halladay, and R L Hale, and de Keczer, and P L Dubin, and B A Ryerson, and A R Read
January 2014, International journal of nanomedicine,
T M Parkinson, and T Honohan, and F E Enderlin, and S C Halladay, and R L Hale, and de Keczer, and P L Dubin, and B A Ryerson, and A R Read
June 1972, The Journal of antibiotics,
T M Parkinson, and T Honohan, and F E Enderlin, and S C Halladay, and R L Hale, and de Keczer, and P L Dubin, and B A Ryerson, and A R Read
February 1974, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie,
T M Parkinson, and T Honohan, and F E Enderlin, and S C Halladay, and R L Hale, and de Keczer, and P L Dubin, and B A Ryerson, and A R Read
March 1946, The Journal of clinical investigation,
Copied contents to your clipboard!